Aims Reversible phosphorylation of mitochondrial proteins is essential in the regulation of respiratory function, energy metabolism, and mitochondrion-mediated cell death. We hypothesized that mitochondrial protein phosphorylation plays a critical role in cardioprotection during pre and postconditioning, two of the most efficient anti-ischaemic therapies. Methods and results Using phosphoproteomic approaches, we investigated the profiles of phosphorylated proteins in Wistar rat heart mitochondria protected by pharmacological pre and postconditioning elicited by isoflurane. Sixty-one spots were detected by two-dimensional blue-native gel electrophoresiscoupled Western blotting using a phospho-Ser/Thr/Tyr-specific antibody, and 45 of these spots were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Eleven protein spots related to oxidative phosphorylation, energy metabolism, chaperone, and carrier functions exhibited significant changes in their phosphorylation state when protected mitochondria were compared with unprotected. Using a phosphopeptide enrichment protocol followed by liquid chromatography-MS/MS, 26 potential phosphorylation sites were identified in 19 proteins. Among these, a novel phosphorylation site was detected in adenine nucleotide translocator-1 (ANT1) at residue Tyr
Introduction
Pre and postconditioning are two of the most effective measures against myocardial infarction, reducing infarct size by up to 70%. Ischaemic preconditioning, first described in 1986, 1 is a biological process, whereby a transient stressful stimulus induces a protective state against a more prolonged, potentially lethal insult. It can be induced by brief ischaemic episodes or by pharmacological means. 2 In contrast, postconditioning, first reported in 2003, 3 is a process whereby ischaemic heart damage is markedly reduced through brief cycles of alternating ischaemia and reperfusion or administration of specific drugs right at the onset of reperfusion. Despite having location at the opposite sites of ischaemia, pre and postconditioning share numerous signalling pathways, 4 including the so-called reperfusion injury salvage kinases ('RISK'), protein kinase B/Akt and p42/44 extracellular signal-regulated kinase 1/2, which converge at the mitochondrial level preventing permeability transition through † Both authors equally contributed to this work. phosphorylation and inhibition of glycogen synthase kinase-3b, 5 by an yet unknown mechanism. Mitochondria plays a central role in ischaemia-reperfusion damage of the heart [6] [7] [8] and hence, are promising targets for novel anti-ischaemic therapies. These complex double membrane-enclosed organelles are not only responsible for ATP production but are also involved in the regulation of cell metabolism, differentiation, Ca 2þ homeostasis, and death signalling. To meet the dynamic cellular requirements, mitochondrial function must be tightly and rapidly regulated. An increasing body of evidence points to protein phosphorylation as the key regulatory mechanism responsible for mitochondrial regulation. 9 Indeed, various kinases, namely protein kinase A, B, C, and G, mitogen-activated protein kinases, glycogen synthase kinase-3b, hexokinase, creatine kinase 2, Src kinase family members were identified in or in close association with mitochondria. [9] [10] [11] [12] [13] Although recent studies shed new light on the role of phosphorylation as an important posttranslational modification in respiratory chain proteins of heart mitochondria, [14] [15] [16] [17] only a limited number of phosphoproteins have been characterized so far.
The aim of this study was to determine the phosphoprotein profiles of pre and postconditioned, i.e. protected heart mitochondria using proteomics analysis and to compare these with the profile of unprotected mitochondria exposed to ischaemia-reperfusion alone. This could ultimately unravel novel phosphorylation sites potentially involved in cardioprotection. Using site-directed mutagenesis in the yeast, an established model of mitochondrial function, the biological significance of one of the newly detected phosphorylation sites, namely Tyr 194 of the adenine nucleotide translocator-1 (ANT1), could be confirmed. Our study adds a new aspect to the mechanisms underlying cardioprotection and points to the importance of mitochondria in this context.
Methods
An expanded Methods section is available in the online data supplement.
Experimental protocols
Hearts from Wistar rats were perfused in a non-circulating Langendorff apparatus with Krebs-Henseleit buffer gassed with 95% O 2 and 5% CO 2 at pH 7.4 and 378C, and subsequently exposed to 40 min of global no-flow ischaemia followed by 15 min of reperfusion ( Figure 1) . Four hearts were assigned to each of the following four groups ( Figure 1 ): (1) CTRL (control group), time-matched perfusion without ischaemia; (2) ISCH, test ischaemia followed by 15 min reperfusion; (3) PreC (pharmacological preconditioning) induced by isoflurane 18 administered for 15 min at 1.5 minimum alveolar concentration (1.5 MAC, corresponding to 2.1 vol%) and washed out for 10 min prior to test ischaemia; (4) PostC (pharmacological postconditioning) induced by 15 min isoflurane administration at 1.5 MAC right at the onset of reperfusion after test ischaemia. The buffer solution was equilibrated with isoflurane using an Isotec 3 vaporizer (Datex-Ohmeda, Tewksbury, MA, USA) with an air bubbler. Isoflurane concentrations were also measured in the buffer solution using a gas chromatograph (Perkin-Elmer, Norwalk, CT, USA): 0.54 + 0.06 mM. Left ventricular developed pressure and coronary flow were recorded as previously described. 19 
Isolation of mitochondria from rat heart tissue
Mitochondrial fractions were isolated as previously described. 20, 21 Briefly, hearts were minced and homogenized in ice-cold homogenization buffer. After centrifugation, crude mitochondria were pelleted from the post-nuclear supernatant by centrifugation. The resultant supernatants were used as cytoplasmic fraction. Enriched mitochondria were resuspended in buffer, and purified in a 25% Percoll density gradient. After washing, mitochondrial proteins were solubilized and purity of the mitochondrial preparations was assessed by Western blotting using specific markers. The following antibodies were used: goat polyclonal anti-ANT antibody (N-19, Santa Cruz Biotechnology, USA), goat polyclonal anti-VDAC1 antibody (N-18, Santa Cruz Biotechnology), mouse monoclonal anti-NDUFS4 (MS104, MitoSciences, Eugene, OR, USA), rabbit polyclonal anti-sMtCK (a kind gift from Dr Theo Wallimann), 22 monoclonal mouse anti-calreticulin (BD Transduction Laboratories, Allschwil, Switzerland), polyclonal rabbit anti-catalase (Calbiochem, UK), and monoclonal anti-alpha tubulin (Sigma, St Louis, MO, USA).
Gel-based proteomics approach
Two-dimensional blue-native/sodium dodecyl sulphate gel electrophoresis (2D-BN-PAGE) was carried out as described by Schägger. 23 Western blotting was performed using monoclonal anti-phosphoSer/Thr/Tyr antibody (SMP101, Assay Designs, LuBioScience, Switzerland). 24 Identification of gel spots was accomplished by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS).
Gel-free proteomics approach
After in-solution digestion, the peptide-containing solution was subjected to strong cation exchange chromatography and immobilized metal ion affinity chromatography for selective phosphopeptide enrichment. Phosphopeptides were identified by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) using linear ion trap-Fourier transform-ion cyclotron resonance and nanoflow reverse-phase high performance liquid chromatography separation followed by MALDI-TOF-MS/MS analysis. 25 
Immunoprecipitation
ANT protein was immunoprecipitated from purified rat heart mitochondrial fractions using goat polyclonal anti-ANT antibody (N-19, Santa Cruz Biotechnology, USA) coupled to protein G-sepharose (Amersham Biosciences).
Preparation of plasmids and yeast culture conditions
The AseI and BamHI fragment of human ANT1 cDNA was amplified by polymerase chain reaction using pcDNA3-myc-ANT1 as a template, which was subcloned into NdeI and BamHI sites of pRS314-YA2P vector to generate pRS314-hANT1. The hANT1 Y194F mutant was 
Statistics
For analysis of protein changes, unpaired t-tests of normalized spot intensities between groups were used. For analysis of haemodynamic data, unpaired t-test was used to compare groups at identical time points, and paired t-test to compare within groups over time (SigmaStat v 2.0; SPSS Science, Chicago, IL, USA). P-values , 0.05 were considered significant.
Results

Effective myocardial protection and purity of mitochondrial fractions from rat hearts
Protection by isoflurane pre and postconditioning was confirmed by functional recovery and coronary flow measurements (see Supplementary material online, Table S1 ). The purity of mitochondrial fractions was carefully checked by Western blot analysis. Figure 2 shows no contamination of the mitochondrial fraction (adenine nucleotide translocator, voltage-dependent anion channel 1, NADH dehydrogenase (ubiquinone) Fe-S protein 4, and sarcomeric mitochondrial creatine kinase) with cytosol (a-tubulin), endoplasmic reticulum (calreticulin), or peroxisome (catalase).
Differences in protein phosphorylation
between protected (pre and postconditioned) vs. unprotected heart mitochondria The BN-PAGE technique allows separation of hydrophobic protein complexes and provides information on their native interactions. The combination of BN-PAGE and SDS-PAGE techniques (2D-BN-PAGE) has become the method of choice for investigating the respiratory chain proteins in mitochondria and other hydrophobic protein complexes. As shown in Figure 3 , only bands for the respiratory complexes I, II, III, IV, and V could be visualized on the first dimension of 2D-BN-PAGE. After SDS-PAGE, the subunits of each complex were resolved (see Supplementary material online, Figure  S1 ). First, protein expression levels were compared and found unchanged between the four groups (data not shown). Next, protein phosphorylation was determined by immunoblotting using a phosphorylation-specific antiphospho-Ser/Thr/Tyr antibody. With this approach, we could detect 61 phosphorylated protein spots per gel ( Figure 3 ). All spots were subjected to MALDI-TOF-MS analysis, and 45 proteins were unequivocally identified and categorized into the following five groups: (1) oxidative phosphorylation (21 subunits); (2) tricarboxylic acid cycle (eight proteins); (3) fatty acid metabolism (11 subunits); (4) transport (three proteins); and (5) chaperones (two proteins; see Table 1 for details). Some proteins displayed multiple spots generated by formation of different complexes, as observed with oxoglutarate dehydrogenase (OGDH), ubiquinolcytochome c reductase complex core protein 2, aspartate aminotransferase (AST), dihydrolipoyllysine-residue succinyltransferase (component of OGDH), aconitate hydratase, malate dehydrogenase, short chain acetyl-CoA dehydrogenase, and adenine nucleotide translocator-1 (ANT1). Interestingly, six of the 61 protein spots were found to be ANT1 indicating that the abundant ANT1 protein forms various complexes in the inner mitochondrial membrane. To better compare the changes of phosphorylated protein spots, the mitochondrial proteins from different groups were first resolved on a 4-13% BN-PAGE. Subsequently, each gel lane was excised and cut into four parts, as indicated in Figure 3 . Matched parts were assembled on the top of a 12% SDS gel and subjected to SDS-PAGE for the second dimension followed by Western blotting with the anti-phospho-Ser/Thr/Tyr antibody. Phosphorylation of 11 spots from seven proteins were found to be significantly changed ( Figure 4 ). Phosphorylation of mitochondrial proteins by two-dimensional bluenative/sodium dodecyl sulphate gel electrophoresis (2D-BN-PAGE) and detection of phosphoproteins. Mitochondrial preparations were first resolved by 4-13% BN-PAGE. Gel slides were cut into four parts, as indicated, and matched parts were assembled on top of a 12% SDS gel for the second dimension SDS-PAGE followed by Western blot with anti-phospho-Ser/Thr/Tyr antibody. A total of 61 protein spots were found to be phosphorylated. Numbers refer to the protein identification presented in Table 1 . of cytochome c oxidase subunit 2 and OGDH were increased in groups subjected to ischaemia-reperfusion injury. In contrast, phosphorylation of NDUFA9, AST, 2,4-dienoyl-CoA reductase, prohibitin-2, and ANT1 were reduced in mitochondria from unprotected hearts (Figure 4 ).
Identification of novel phosphorylation sites in cardiac mitochondrial proteins
We identified 26 different phosphorylation sites in 19 proteins ( Table 2) . Twenty-four serine/threonine residues and two tyrosine residues were found. Except for malate dehydrogenase, aconitate hydratase, and ANT1, the other 16 proteins could not be found by 2D-BN-PAGE/Western blot with anti-phospho-Ser/Thr/Tyr antibody. Two of the 19 proteins contained two distinct phosphorylation sites, while one protein (pyruvate dehydrogenase E1 alpha subunit) contained six different sites. The exact position of the phosphorylated residues could not be assigned in three proteins. The MS/MS spectrum of ANT1, the major isoform of the ADP/ATP translocator in the heart, containing a phosphorylated tyrosine (Tyr 194 ), is depicted in Figure 5 . Additional MS/MS spectra of identified phosphopeptides are shown as online supplemental data (see Supplementary material online, Figure S2 ).
Modulation of adenine nucleotide translocator phosphorylation by pre and postconditioning
The phosphorylation of ANT1 is of particular interest, as this protein is not only essential for the transport of ATP produced by oxidative respiration, but is also thought to be an integral component of the mitochondrial permeability transition pore. 6 To confirm the changes in ANT phosphorylation by pre and postconditioning, ANT protein was immunoprecipitated from all samples, and the phosphorylation of ANT was visualized by Western blot with anti-phospho-Tyr antibody. As shown in Figure 6 , ANT phosphorylation was reduced after ischaemia-reperfusion alone (unprotected state). ANT dephosphorylation could be prevented by both protective therapies, i.e. preconditioning and postconditioning. It is well-known that the ADP/ATP carriers (AACs), the yeast homologues of the mammalian ANT, are essential for oxidative phosphorylation, i.e. AAC-deficient yeast grows exclusively on fermentable media. Deletion of all the three AAC genes in yeast results in oxidative phosphorylation-deficient cells unable to grow on respiratory carbon sources (JL-1-3 strain). However, AAC-deficient yeast can grow in the presence of non-fermentable carbon sources, such as glycerol or lactate if expressing any of the three human ANT isoforms. Re-expression of human ANT1 restores growth of JL-1-3 yeast cells in both glycerol and lactate plates, as shown in Figure 7 . To test whether phosphorylation at Tyr 194 is required for yeast growth, we substituted Tyr 194 by phenylalanine to create a non-phosphorylatable residue in ANT1 (ANT1 Y194F ). Re-expression of the ANT1 Y194F mutant into JL-1-3 yeast cells was unable to restore growth on non-fermentable carbon sources (Figure 7) . Hence, loss of ANT phosphorylation at Tyr 194 results in a defective oxidative growth phenotype. 
Discussion
Our study focused on the systematic profiling of phosphoproteins in heart mitochondria. Since recent studies provide evidence that reversible phosphorylation of mitochondrial proteins is more common than previously expected, [14] [15] [16] [17] and that this might be essential in the context of cardioprotection, we set out to assess the mitochondrial phosphoproteome in pre and postconditioned, i.e. protected heart mitochondria, and to compare this with the mitochondrial phosphoprotein profile of unprotected hearts. The ultimate goal was to identify novel anti-ischaemic targets. For this purpose, a gel-based approach, combining 2D-BN-PAGE, 23 Western blot analysis, 24 and MALDI-TOF-MS, and a gel-free phosphoproteomics approach including two phosphopeptide enrichment steps followed by LC-ESI-MS/MS or LC-MALDI-MS/ MS 25 were used. The native gel-based method is widely used for both protein profiling and quantitative proteomic analyses, specifically for organelles like mitochondria, but it may suffer from difficulties in detecting low-abundance, very large, or small proteins. Using this technique, we identified a total of 61 phosphorylated proteins from rat heart mitochondria covering a wide range of key mitochondrial functions such as oxidative phosphorylation, tricarboxylic acid cycle, lipid metabolism, and transport or chaperone activities. For example, some oxidative phosphorylation units (NADH dehydrogenase Fe-S protein 7, NADH dehydrogenase 1 beta-4, ubiquinol-cytochrome c reductase complex core protein 2, cytochrome c oxidase subunit 4 isoform 1, and succinate dehydrogenase complex subunit B), and many of the proteins involved in lipid metabolism (propionyl-CoA carboxylase beta chain, trifunctional enzyme subunit alpha and beta, 2,4-dienoyl-CoA reductase, 3,2-trans-enoyl-CoA isomerase, short chain 3-hydroxyacyl-CoA dehydrogenase, and carnitine O-palmitoyltransferase 2) have not yet been reported to be phosphorylated in cardiac mitochondria. After selective enrichment of phosphopeptides and liquid chromatography followed by mass spectrometry, we were able to increase proteome coverage and to map 26 phosphorylation sites in 19 proteins. Many of the 26 identified phosphorylation sites in cardiac mitochondrial proteins are reported here for the first time. 26, 27 Together, our observations suggest that phosphorylation may play a more prominent regulatory role in heart mitochondria than previously thought.
Although protective signalling pathways of pre and postconditioning converge at the mitochondrial level, 5, 7 little is known about the post-translational modifications of possible end-effectors involved in cardioprotection. Recently, a number of protein kinases and phosphatases were found to colocalize with various mitochondrial sub-compartments, 9, 11 but the ultimate targets of these kinases remain largely unknown. Using an isolated rabbit heart model, Kim et al. 28 compared the changes in protein expression of ischaemia-preconditioned mitochondria with non-preconditioned mitochondria and identified 25 differentially expressed mitochondrial proteins. Most of these proteins were related to Figure 4 Differentially altered phosphoprotein spots, as identified by comparative two-dimensional blue-native/sodium dodecyl sulphate gel electrophoresis (2D-BN-PAGE) and Western blot analysis. Regions of 2D-blots with reproducible protein alterations were boxed, and the protein spots were identified by mass spectrometry. NDUFA9, NADH dehydrogenase ubiquinone 1 alpha subcomplex 9; AST, aspartate aminotransferase; ANT1, adenine nucleotide translocator-1. CTRL: time-matched perfusion; ISCH: hearts exposed to ischaemia-reperfusion; PreC, isoflurane preconditioning; PostC: isoflurane postconditioning. Data are mean + SD (n ¼ 4). Statistically significant changes relative to CTRL are indicated using two-tailed unpaired t-test: *P , 0.05. respiratory chain and energy metabolism. In another study by Arrell et al., 29 isolated rabbit cardiomyocytes were preconditioned with adenosine and diazoxide, but no index ischaemia was applied. After 2 h of drug exposure, whole cell lysates were collected and subjected to 2D-gel electrophoresis. This study identified 28 differentially expressed protein spots, the majority of which again was involved in bioenergetics. Interestingly, the same study also found four new phosphorylation sites, one at the b-subunit of ATP-synthase. While both studies predominantly focused on changes in protein expression, fundamental changes in heart physiology may typically occur without changes in protein abundance but rather in response to posttranslational modifications such as phosphorylation. Comparing the phosphorylation profiles of protected vs. unprotected mitochondria, we were able to identify seven proteins from 11 spots that were differentially phosphorylated. Phosphorylation of cytochrome c oxidase subunit 2 and OGDH were increased in protected and unprotected mitochondria, suggesting that phosphorylation of these proteins may be related to ischaemiareperfusion injury. In contrast, phosphorylation of NDUFA9, AST, 2,4-dienoyl-CoA reductase, prohibitin-2, and ANT1 were exclusively reduced by ischaemia-reperfusion alone, but largely unaffected by both pre and postconditioning. Hence, phosphorylation of these sites may be rather linked to cardioprotection.
To test whether the observed phosphorylation of ANT1 was indeed linked to biological significance and to exclude the possibility of mere association or experimental artefacts, we determined the biological significance of the novel phosphorylation site of ANT1 at residue Tyr 194 . ANT, called AAC in yeast, is the most abundant protein of the inner mitochondrial membrane and belongs to the mitochondrial solute carrier family involved in a variety of transport activities across the inner mitochondrial membrane. 30 ANT facilitates the exchange of ADP/ATP by an antiport mechanism and thus is essential for the utilization of ATP produced by oxidative phosphorylation. Moreover, ANT is thought to be an integral component of the mitochondrial permeability transition pore (mPTP), 19 albeit this function is still under debate. 31 Current evidence suggests that cardioprotection by pre and postconditioning is ultimately mediated through the inhibition of mitochondrial permeability transition. Baines et al. 32 reported that PKC1 closely interacts with cardiac mitochondria implying that components of the mPTP complex might be the principal target of this kinase. In our study, we could show that ischaemia-induced ANT dephosphorylation could be prevented or reversed by both pre and postconditioning. A major phosphorylation site of ANT was identified on to Phe, mimicking the non-phosphorylated state, failed to rescue cellular growth on a non-fermentable carbon source when transforming the human ANT1 into the AAC-deficient yeast strain JL-1-3. Therefore, our results provide evidence that this phosphorylation site is critical for mitochondrial bioenergetics, which is in accordance with the previous reports showing that tyrosine phosphorylation of Phosphorylation of adenine nucleotide translocator (ANT) in heart mitochondria. ANT protein was immunoprecipitated from 50 mg of purified rat heart mitochondrial fractions and subjected to Western blot with anti-phospho-tyrosine antibody. Representative Western blots (upper) and averaged density data of phosphorylated tyrosine of ANT (p-Tyr) compared with total ANT (t-ANT) are shown for each group. IgG LC: light chain of goat ANT antibody; CTRL: time-matched perfusion; ISCH: hearts exposed to ischaemia-reperfusion alone; PreC, isoflurane preconditioning; PostC: isoflurane postconditioning. Data are mean + SD (n ¼ 4). *P , 0.05 vs. ISCH. mitochondrial proteins is enhancing ATP production. 34 Although the yeast experiments extend our proteomic findings from isolated rat hearts showing that Tyr194 phosphorylation of ANT1 is associated with cardioprotection, future experiments using hypoxia/reoxygenation will have to prove this concept in mammalian cells.
In our comparative phosphoproteomics study, we used 2D-BN-PAGE-coupled Western blotting with an antibody specific for phospho-Ser/Thr/Tyr. Although this approach is comparable with those using fluorescent phosphosensor dyes (ProQ Diamond dye), it is conceivable that some phosphoproteins may remain undetected by either methods. 35 In addition, some proteins may be dephosphorylated during the mitochondria isolation process or even during BN-PAGE. Because of the lack of antibodies, we were unable to confirm all the observed changes in phosphorylation by immunoprecipitation. Besides phosphorylation, we found other modifications in mitochondrial proteins. For example, tryptophan modifications (kynurenine and formylkynurenine), which have a profound impact on cell death and survival and are implicated in a number of pathologies, 36 were frequently observed in our study (data not shown). This is not so much surprising since mitochondrial proteins are exposed to high amounts of reactive oxygen species. In addition, histidine 37 and cysteine 38 phosphorylation was also observed (His 292 of pyruvate dehydrogenase E1 alpha subunit and Cys 63 of sarcomeric mitochondrial creatine kinase). Although histidine and cysteine phosphorylation were previously reported, their physiological relevance remains largely unknown. In the current study, the halogenated ether isoflurane was used to elicit pre and postconditioning in hearts. This class of drugs was proven to be of value in the clinical setting of patients undergoing coronary artery bypass grafting surgery. 39, 40 However, it is possible that other pre and postconditioning mimicking agents may elicit different phosphoprotein profiles in heart mitochondria.
In summary, our comparative analysis of mitochondrial phosphoproteins in pre and postconditioned, i.e. protected vs. unprotected mitochondria, revealed a total of 61 phosphoproteins including 26 phosphorylation sites and it proved to be an effective approach for elucidating the molecular events underlying ischaemic injury and protective mechanisms. A major phosphorylation site was identified in ANT1 at Tyr 194 . The substitution of this site with Phe, mimicking the non-phosphorylated state, resulted in the complete inhibition of oxidative growth in the yeast model suggesting that phosphorylation at this novel site is critical for bioenergetics and may thus substantially contribute to cardioprotection.
Supplementary material
Supplementary material is available at Cardiovascular Research online. Figure 7 Yeast growth on fermentable and non-fermentable substrates. The Saccharomyces cerevisiae strain JL-1-3 was transformed with pRS314-YA2P encoding human ANT1 wild-type and ANT1
Y194F
. Transformants were plated on yeast extract peptone dextrose, YPGly, and YPLact plates. After three days of incubation at 288C on yeast extract peptone dextrose and seven days on YPGly and YPLact, the plates were photographed. W303-1B denotes haploid strain of S. cerevisiae.
